Categories Billion Dollar Club

Merck & Company Inc. (MRK) Climbs to Annual-High Share Price

Merck & Company Inc. (NYSE:MRK) traded at a new 12-month high today of $91.79. Approximately 3.7 million shares have changed hands today, as compared to an average 30-day volume of 12 million shares.

Merck & Company Inc. share prices have moved between a 12-month high of $91.79 and a 12-month low of $70.89 and are now trading 29% above that low price at $91.61 per share.

Based on a current price of $91.61, Merck & Company Inc. is currently 9.1% above its average consensus analyst price target of $83.27.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm’s immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm’s sales are generated in the United States.

About BillionDollarClub

BillionDollarClub (BDC) is the exclusive home of the biggest and brightest companies covered by IBN, a financial news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution to nearly 2 million followers, and (5) a full array of corporate communications solutions. This is the place you want to be, where every covered company has a market cap in excess of $1 billion. By cutting through the overload of information in today’s market, BDC brings its clients unparalleled visibility, recognition and brand awareness. While IBN’s client list includes companies big and small, BillionDollarClub is the gold standard.

To receive SMS text alerts from BillionDollarClub, text “Billion” to 888-902-4192  (U.S. Mobile Phones Only)

For more information, please visit https://www.BillionDollarClub.com

Please see full terms of use and disclaimers on the BillionDollarClub website applicable to all content provided by BDC, wherever published or re-published: http://IBN.fm/Disclaimer

BillionDollarClub (BDC)
Los Angeles, California
www.BillionDollarClub.com
310.299.1717 Office
Editor@BillionDollarClub.com

BillionDollarClub is part of the InvestorBrandNetwork.

BillionDollarClub

Share
Published by
BillionDollarClub

Recent Posts

Bitcoin ETFs Record First Half-Year of Net Outflows

Bitcoin spot exchange-traded funds posted their first negative six-month performance since entering the market, marking…

3 hours ago

VERAXA Biotech AG (NASDAQ: VRXA) Advances Lead BiTAC(R) T-Cell Engager Program with Cell Line Development Partnership

The company has initiated cell line development for its lead BiTAC(R) T-cell engager program, selecting…

1 day ago

France to Relaunch its Social Leasing EV Program in July

France will relaunch the country’s social leasing electric vehicle (EV) program on July 16, 2026…

2 days ago

South Korea Earmarks $1 Trillion for Chip, AI Investment

South Korea has announced one of its biggest technology investment plans ever. The country plans…

3 days ago

Why Wall Street Watches Jefferies’ Earnings Reports Closely

Jefferies Financial may not be as large as Wall Street giants like Goldman Sachs, Morgan…

1 week ago

Why VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Pay Serious Attention to Antibody Therapeutics Sector Deals

Deal activity remains strong in antibody-drug conjugates (ADCs) and T-cell engager (TCE) therapeutics, with pharmaceutical…

1 week ago